SCHEMBL22044355

SCHEMBL22044355

Cc1ccc(N)c(C(C)(c2ccc(-c3ccccc3)cc2)c2cc(C)ccc2N)c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 2/20 0.46
MEN1 O00255 2/20 0.40
KMT2A Q03164 2/20 0.40
HDAC2 Q92769 3/20 0.39
ALOX15 P16050 2/20 0.38
CYP3A4 P08684 2/20 0.38
TDP1 Q9NUW8 2/20 0.38
TP53 P04637 1/20 0.38
THRB P10828 1/20 0.38
PGR P06401 1/20 0.38
ESR1 P03372 2/20 0.37
ESR2 Q92731 2/20 0.37
CNR1 P21554 1/20 0.36
CNR2 P34972 1/20 0.36
KIF11 P52732 4/20 0.36
HSD17B10 Q99714 2/20 0.36
MAPT P10636 2/20 0.36
KDM4E B2RXH2 1/20 0.36
USP2 O75604 1/20 0.36
ALDH1A1 P00352 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22044362 0.90 SMN1; SMN2 (0.51) SMN1; SMN2ALOX15CYP3A4TDP1TP53
SCHEMBL22051103 0.84 HSD17B10 (0.48) SMN1; SMN2MEN1KMT2AHDAC2ALOX15
SCHEMBL22050398 0.84 SMN1; SMN2 (0.42) SMN1; SMN2MEN1KMT2AHDAC2ALOX15
SCHEMBL22051885 0.83 KIF11 (0.52) MEN1KMT2AHDAC2CYP3A4PGR
SCHEMBL22050649 0.81 ESR1 (0.40) SMN1; SMN2MEN1KMT2ACYP3A4TDP1
SCHEMBL22051882 0.80 HDAC2 (0.44) SMN1; SMN2MEN1KMT2AHDAC2CYP3A4
SCHEMBL22051862 0.79 HSD17B10 (0.45) SMN1; SMN2MEN1KMT2AHDAC2ALOX15
SCHEMBL22044357 0.78 ESR1 (0.51) SMN1; SMN2MEN1KMT2AHDAC2ALOX15
SCHEMBL22737749 0.77 KIF11 (0.40) MEN1KMT2ATDP1ESR1ESR2
SCHEMBL22051073 0.76 ESR1 (0.49) MEN1KMT2AALOX15CYP3A4TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200172470-A1 NOVEL (POLY)AMINE COMPOUND, RESIN AND CURED PRODUCT MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 2020-06-04 US disclosed
EP-3659996-A1 NOVEL (POLY)AMINE COMPOUND, RESIN, AND CURED PRODUCT Mitsubishi Gas Chemical Company, Inc. (JP) 2020-06-03 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200172470-A1 NOVEL (POLY)AMINE COMPOUND, RESIN AND CURED PRODUCT PAM, CBR1, KDM1A SMN1; SMN2 958/4885MEN1 3096/4885KMT2A 55/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.